You just read:

Innovent Provides Update on the Results of IBI305 for the First-line Treatment of Advanced Non-squamous Cell Lung Cancer by Oral Presentation at CSCO

News provided by

Innovent Biologics

Sep 19, 2019, 04:28 ET